The field of chemical synthesis is constantly evolving, driven by the pursuit of greater efficiency, sustainability, and novel molecular structures. Key intermediates, such as 2-hydroxy-4-aminobutanoic acid (CAS 13477-53-7), serve as foundational elements in these advancements. NINGBO INNO PHARMCHEM CO.,LTD. recognizes this compound's potential beyond its established role, highlighting its utility in innovative chemical processes.

While 2-hydroxy-4-aminobutanoic acid is predominantly known as an intermediate for amikacin synthesis, its structure, featuring both hydroxyl and amino functional groups on a butyric acid backbone, suggests broader applicability. The presence of a chiral center further enhances its value as a versatile building block for stereoselective synthesis. Researchers and process chemists are continually exploring new methodologies to leverage such compounds for creating complex organic molecules, including novel pharmaceuticals, agrochemicals, and specialty materials. The high purity and defined properties of this amino acid derivative in pharmaceuticals are crucial for these experimental and developmental stages.

NINGBO INNO PHARMCHEM CO.,LTD. supports these innovative endeavors by providing reliable access to high-quality 2-hydroxy-4-aminobutanoic acid. As a supplier of essential specialty organic synthesis chemicals, we understand that consistency in products like this pharmaceutical intermediate is key to reproducible research and scaled-up production. The meticulous control over its appearance (white crystalline powder), melting point, specific rotation, and assay (≥98.5%) by our company ensures that it can be effectively integrated into various advanced chemical synthesis protocols.

The development of more efficient and greener synthesis routes is a major focus in modern chemistry. Intermediates like 2-hydroxy-4-aminobutanoic acid, when sourced from reputable manufacturers like NINGBO INNO PHARMCHEM CO.,LTD., contribute to these goals by providing a reliable starting point. This ensures that the pharmaceutical precursor supply chain is not only robust but also capable of supporting cutting-edge research and development. By offering this compound, we aim to empower chemists and manufacturers to push the boundaries of what is possible in chemical innovation and the production of fine chemical intermediates for drug manufacturing.